Respiratory drugs - Asthma pharmacology
Asthma= chronic disease characterized by Hyperresponsive airway, characterized by Bronchoconstriction, shortness of breath, cough, chest tightness, wheezing, rapid respiration
COPD= Irreversible obstruction of airway include Emphysema and chronic Bronchitis
Allergic Rhinitis
Inflammation of mucous memb. Of nose characterized by itchy, watery eyes, runny nose, unproductive cough, nasal congestion
Cough
defensive respiratory response to irritants Meterd –dose inhaler= contain Ozone-depleting Chlorofluorocarbons...SLOWLY & DEEPLY technique ….Nedocromil, Metaproterenol, Cromolyn, Flunisolide,
Albuterol/Ipratropium, Pirbuterol
New formulations are environment friendly include HydrofuoroAlkanes & Dry powder inhaler (DPIs) ….DPI technique QUICKLY, DEEPLY
Drugs for Asthma
Epinephrine DOC in Acute Anaphylaxis & Status Asthmaticus
Quick relief= by Short-acting β2- Agonists e.g ALBUTEROL 5-30min onset, 6-4hr t1/2 not catecholamine , not hydrolyzed by COMT…
S.E; Hypokalemia, Hypomagnesemia, Hyperglycemia
Long-term control (LABAs)
Salmeterol, Xinafoate, Formoterol long acting β2 agonist… Salmeterol & Formoterol 12hr bronchodilation…single agent used is contraindicated... used in Adjunct therapy…
Corticosteroid DOC in long duration
Corticosteroid
Inhaled Corticosteroid (ICS) DOC in persistent Asthma…NHLBI national Heart, Lung, Blood institute provide “SET UP” therapy;
Dose of ICS therapy
according to Patients Asthma Classification
MDI Slowly, Deeply for ICS….DPI Quickly, Deeply for ICS…”Swish & Spit” with H2O to reduce side effects
Leukotrienes Antagonists
Leukotriene (LT) B4 and Cysteinyl Leukotriene , LTC4, LTD4, LTE4…..products of 5-Lipoxygenase pathway of Arachidonic Acid metabolism….5-Lipoxygenase found in Mast cells, Basophil, Eoisniophil , Neutrophil…..
LTB4 potent Chemoatractant for Neutrophil & Eosinophil
Cysteinyl Leukotriene constricts Bronchiolar Smooth Muscle, increase Endothelial Permeability, and promote Mucus secretion
Zileuton is Selective inhibitor of 5-Lipoxygenase, prevent formation of LTB4 & Cyteinyl Leukotriene…
Zafirleukast & Montelukast Selective & Reversible Inhibitor of Cysteinyl Leukotriene-1 receptor…
Montelukast Market Leader in this class due to; 1) Dosing recommendation in children of 6 month & older,
2) Available in Chewable tab & Granule formation….improved for Exercise-Induced Asthma
All these medicines used for Prophylaxis of Asthma but not for immediate effect
S.E= increase LFTs, Eosinophilic vasculitis (Churg-Strauss Syndrome), Dyspepsia,
Cromolyn
Prophylactic Anti-inflammatory Agent…not useful in managing Acute Asthma Attack… not Direct Bronchodilator…. Inhibit Mast cell Degranulation & Release of Histamine…. Block initiation of Immediate & Delayed Asthmatic reaction …
Pretreatment
prevent Allergen & Exercise-induced Asthma
Nebulizer from….
Short duration, frequent dosing
Cholinergic Antagonists (Tiotropium, Ipratropium)
Inhaled Ipratropium= Quaternary derivative of Atropine….Block Vegally mediated
Contraction of Airway Smooth muscle & Mucus Secretion…..free of side effect….
Effective for patient having Asthma with COPD
Theophylline
Bronchodilator…Block Phosphodiestrase , Increase cAMP, Block Adenosine ,
Decrease Ca++ in smooth muscle……used in Chronic Asthma…..FDA not recommend it now…
cause Seizure, Arrhythmia….drug interaction due to CYP1A2,3A4 substrate
Omalizumab
Recombinant DNA Monoclonal antibody….selectively bind to IgE….decrease binding of
IgE to mast cell & Basophil receptor….decrease release of Allergic mediator
Used in moderate to severe Allergic Asthma
Treatment Guidelines of Asthma
Comments
Post a Comment